As expected everyone in the mainstream media sees the Livongo/Teladoc merger as a watershed event for digital health. Ironically the Street wasn't that impressed as Livongo shares fell by over 11% while Teladoc shares fell over 19%.
The real question we have is will these two companies actually consummate this marriage or will one of the nuptials get cold feet at the alter? According to everything we have read the deal is supposed to close sometime in the fourth quarter which means there is plenty of time for a change of heart. Given the amount of money . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.